NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study
Morgane Cheminant(Hôpital Necker-Enfants Malades), Olivier Hermine(Centre National de la Recherche Scientifique), Nadine Cerf–Bensussan(Université Paris Cité), Sascha Cording(Inserm), Richard Delarue(Délégation Paris 5), Amélie Trinquand(Hôpital Necker-Enfants Malades), Nicole Brousse(Hôpital Necker-Enfants Malades), Florence Lhospice(Innate Pharma (France)), Laurent Pouyet, Tom van Gils(University of Gothenburg), Julie Bruneau(Délégation Paris 5), Felipe Suárez(Hôpital Necker-Enfants Malades), Shérine Khater(Hôpital Européen Georges-Pompidou), Christophe Cellier(Assistance Publique – Hôpitaux de Paris), Vahid Asnafi(Hôpital Necker-Enfants Malades), Anne‐Sophie Jannot(Inserm), Ludovic Lhermitte(Hôpital Necker-Enfants Malades), Elizabeth Macintyre(Inserm), Chris J. Mulder(Amsterdam University Medical Centers), Cécile Bonnafous(Innate Pharma (France)), Georgia Malamut(Délégation Paris 5), Thierry Jo Molina(Hôpital Necker-Enfants Malades), Ambroise Marçais(Hôpital Necker-Enfants Malades), Nicolas Guégan(Délégation Paris 5), David Sibon(Hôpital Necker-Enfants Malades), Virginie Verkarre(Université Paris Cité), Laurent Frenzel(Hôpital Necker-Enfants Malades), Bertrand Meresse(Centre Hospitalier Universitaire de Lille)
Cited by 62
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k